Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,738
datasets available to search
ShareScore release 0.9.0
Dataset results
2,738 results for “Multiple Sclerosis”
Study of Oral Fampridine-SR in Multiple Sclerosis
ClinicalTrials.gov study NCT00127530. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Telephone-Delivered Exercise for Multiple Sclerosis Fatigue
ClinicalTrials.gov study NCT03256851. IPD Sharing: NO. Countries: 1. Publications: 1.
Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple Sclerosis
ClinicalTrials.gov study NCT03185065. IPD Sharing: NO. Countries: 1. Publications: 2.
A Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD)
ClinicalTrials.gov study NCT00436826. IPD Sharing: Not stated. Countries: 4. Publications: 2.
A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS)
ClinicalTrials.gov study NCT00642902. IPD Sharing: Not stated. Countries: 17. Publications: 1.
Teleconference Fatigue Management for People With Multiple Sclerosis
ClinicalTrials.gov study NCT00591721. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT01457924. IPD Sharing: Not stated. Countries: 11. Publications: 1.
A Randomized Trial of Two Formal Group Programs for Multiple Sclerosis
ClinicalTrials.gov study NCT01918800. IPD Sharing: YES. Countries: 1. Publications: 3.
Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis
ClinicalTrials.gov study NCT00179478. IPD Sharing: NO. Countries: 2. Publications: 5.
Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants Who Have Participated in Cladribine Clinical Trials
ClinicalTrials.gov study NCT01013350. IPD Sharing: Not stated. Countries: 1. Publications: 1.
BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment) and BENEFIT Follow-up Study
ClinicalTrials.gov study NCT00185211. IPD Sharing: Not stated. Countries: 20. Publications: 14.
American Ginseng Treatment for Multiple Sclerosis Related Fatigue
ClinicalTrials.gov study NCT00754832. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
ClinicalTrials.gov study NCT02219932. IPD Sharing: Not stated. Countries: 11. Publications: 1.
A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT04075266. IPD Sharing: YES. Countries: 3. Publications: 1.
Testosterone Treatment for Multiple Sclerosis
ClinicalTrials.gov study NCT00405353. IPD Sharing: NO. Countries: 1. Publications: 4.
Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.
ClinicalTrials.gov study NCT02097849. IPD Sharing: Not stated. Countries: 1. Publications: 1.
BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)
ClinicalTrials.gov study NCT00605215. IPD Sharing: Not stated. Countries: 19. Publications: 2.
Vaginal Estriol in Multiple Sclerosis
ClinicalTrials.gov study NCT03774407. IPD Sharing: NO. Countries: 1. Publications: 7.
Effect of Physical ACtivity in Fingolimod Treated patiEnts (PACE) With Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT01490840. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis
ClinicalTrials.gov study NCT00246324. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.